Thursday, April 24, 2014 4:49:14 PM
2 hours ago
Posted in News, Avian Influenza, World Health Organization (WHO)
The National Health and Family Planning Commission (NHFPC) of China has notified the World Health Organization (WHO) of six additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus.
Details of the cases reported on April 23, 2014 are as follows:
A 35-year-old healthcare worker from Wuxi City, Jiangsu Province became ill on April 10, was admitted to a hospital on April 14 and is currently in a critical condition.
A 50-year-old man from Yongzhou City, Hunan province became ill on April 10, was admitted to a hospital on April 19 and is currently in a critical condition.
Details of the cases as reported on April 21, 2014 are as follows:
A 34-year-old man from Wuxi City, Jiangsu Province became ill on April 10, was admitted to a hospital on 16 April, and is currently in a critical condition.
A 55-year-old woman from Shantou City, Guangdong Province became ill on April 6, was admitted to a local hospital on April 17, and is currently in a critical condition.
Details of the cases notified on April 17, 2014 are as follows:
A 60-year-old man from Changzhou City, Jiangsu Province became ill on April 8, was admitted to a hospital on April 13, and is currently in a severe condition. He had a history of contact with poultry before he became ill.
A 70-year-old man from Tongling City, Anhui Province became ill on March 21, was admitted to a hospital on March 25, and died on April 14.
The Chinese government has taken the following surveillance and control measures: strengthen surveillance and situation analysis; reinforce case management and treatment; and conduct risk communication with the public and release information.
The previous report of avian influenza A(H7N9) virus detection in live poultry exported from mainland China to Hong Kong SAR shows the potential for the virus to spread through movement of live poultry, at this time there is no indication that international spread of avian influenza A(H7N9) has occurred. However as the virus infection does not cause signs of disease in poultry, continued surveillance is needed. Further sporadic human cases of avian influenza A(H7N9) infection are expected in affected and possibly neighbouring areas.
Should human cases from affected areas travel internationally, their infection may be detected in another country during or after arrival. If this were to occur, community level spread is unlikely as the virus does not have the ability to transmit easily among humans. Until the virus adapts itself for efficient human-to-human transmission, the risk of ongoing international spread of H7N9 virus by travelers is low.
WHO advises that travelers to countries with known outbreaks of avian influenza should avoid poultry farms, or contact with animals in live bird markets, or entering areas where poultry may be slaughtered, or contact with any surfaces that appear to be contaminated with feces from poultry or other animals. Travellers should also wash their hands often with soap and water. Travellers should follow good food safety and good food hygiene practices.
WHO does not advise special screening at points of entry with regard to this event, nor does it currently recommend any travel or trade restrictions.
As always, a diagnosis of infection with an avian influenza virus should be considered in individuals who develop severe acute respiratory symptoms while travelling or soon after returning from an area where avian influenza is a concern.
WHO encourages countries to continue strengthening influenza surveillance, including surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns, in order to ensure reporting of human infections under the IHR (2005), and continue national health preparedness actions.
Source: WHO
http://www.infectioncontroltoday.com/news/2014/04/six-cases-of-human-infection-with-h7n9-virus-are-reported-to-who.aspx
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM